Stephen J. Hill, Chief Operating Officer at Lyell Immunopharma, Inc. (LYEL), sold 89 shares at $18.92 ($2K) on 2026-05-11, disclosed to the SEC on 2026-06-15.
Open-market sale of $2k LYEL by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| LYEL | SELL | 2026-02-12 | $29K | — | Filing → |
| LYEL | SELL | 2026-02-11 | $3K | — | Filing → |
| LYEL | SELL | 2025-11-12 | $2K | — | Filing → |